China has declared an accelerated push toward technological self-reliance as a cornerstone of its national development strategy. Science and Technology Minister Yin Hejun outlined a comprehensive roadmap for the 2026-2030 period following the opening session of the National People’s Congress, positioning scientific innovation as critical to China’s transformation into a global technology leader.
The strategic blueprint emphasizes original and pioneering research across the entire innovation chain. Minister Yin highlighted intensified focus on strengthening basic research infrastructure while advancing cutting-edge domains including artificial intelligence, quantum technology, biomanufacturing, and nuclear fusion. The approach marks a significant shift from conventional research conversion models toward integrated planning of technological and industrial innovation.
Technological advancement is positioned as the driving force behind new quality productive forces and modernized industrial systems. The ministry plans to enhance coordination across China’s national innovation ecosystem, particularly leveraging three major international science hubs: Beijing-Tianjin-Hebei, Yangtze River Delta, and Guangdong-Hong Kong-Macao Greater Bay Area. These regions will serve as primary innovation sources, industry leadership centers, and talent attraction clusters.
Substantial infrastructure development accompanies the strategy, including construction of major scientific facilities, establishment of world-class academic journals and databases, and reforms to science evaluation systems. While emphasizing domestic capability building, the plan also commits to international scientific cooperation through leadership in major global research initiatives.
The commitment follows demonstrated progress in China’s innovation capacity. The nation climbed to 10th position in the global innovation index, with 2025 research investment exceeding 3.92 trillion yuan ($570 billion). A landmark achievement saw basic research funding reach 7.08% of total R&D expenditure, surpassing the 7% threshold for the first time. These investments have yielded breakthroughs in open-source large models, semiconductor chips, and pharmaceutical innovations.